stock options

Shakti Pumps (India) Limited’s shares rose 4.76 per cent after the company secured its 14th patent for a new motor technology. The patent, titled “Method and Apparatus for Soft Start, Soft Stop, Protection & Brown Out Operation of a Grid-Connected Motor,” was awarded by the Patent Office, Government of India, in accordance with the Patents Act of 1970. This patent is valid for 20 years from the date of filing.

Market tracker CarIsYou said on Thursday that hybrid vehicle registrations in South Korea increased 41% year-on-year in the first four months of this year amid a slowdown in pure electric vehicle sales.

Gelonghui, May 23 | Cyrusdela Rubia, chief economist of Hamburg Commerzbank, said that today’s Eurozone data couldn’t look better.

Gelonghui, May 23 | NVIDIA (NVDA.US) U.S. stocks rose nearly 7% before the market opened, to US$1,015.29, and are likely to hit a record high after the opening.

DuPont plans to spin off into three publicly traded companies, joining a group of industrial conglomerates seeking to boost returns by breaking into smaller, more focused businesses.

Standard & Poor\’s on Wednesday raised SoftBank Group\’s long-term credit rating by one notch to BB+, still junk level, with a stable rating outlook, as it expects the company to be able to maintain a relatively stable financial position in the short term.

Strides Pharma Science Ltd’s shares were up by 0.76 per cent after the company said its step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, Singapore, had received approval from the United States Food & Drug Administration (USFDA) for the generic version of Sucralfate Oral Suspension, 1gm/10 mL.

Glenmark Pharmaceuticals Ltd.’s subsidiary Glenmark Specialty S.A., entered a marketing and distribution agreement with BeiGene, a global oncology company. This partnership will see Glenmark handle the local development, registration, and distribution of BeiGene’s oncology medicines, Tislelizumab and Zanubrutinib, in India. Tislelizumab, an anti-PD-1 monoclonal antibody, is approved for advanced esophageal squamous cell carcinoma, among other cancers, while Zanubrutinib, a BTK inhibitor, is used for certain hematological malignancies.

Balu Forge Industries Ltd. announced expansion with the establishment of a forging capacity of 72,000 tons annually. This expansion includes the acquisition of three new forging production lines: a 16-ton closed die forging hammer, a 10-ton closed die forging hammer, and an 8,000-ton capacity mechanical press. These facilities will be part of BFIL’s new greenfield project in Belagavi, Karnataka.

Germany\’s DAX index fell 0.12%, France\’s CAC40 index fell 0.33%, Britain\’s FTSE 100 index fell 0.4%, and Europe\’s Stoxx 50 index fell 0.34%.